Literature DB >> 2289530

Tetrahydroaminoacridine induces opposite changes in muscarinic and nicotinic receptors in rat brain.

L Nilsson-Håkansson1, Z Lai, A Nordberg.   

Abstract

Rats were treated with 10 mg/kg tetrahydroaminoacridine (THA) twice daily for 14 days. THA (10 mg/kg) induced a significant decrease in the number of muscarinic receptors (both M1 and M2) in the cortex and striatum, whereas the number of nicotinic receptors in the cortex and hippocampus increased. Rats treated with physostigmine (0.9 mg/kg) showed a reduced number of muscarinic receptors, but no change in nicotinic receptors. The results indicate that treatment with cholinesterase inhibitors can induce opposite changes in brain muscarinic and nicotinic receptors in vivo.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2289530     DOI: 10.1016/0014-2999(90)90448-f

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  Chronic treatments with cholinoceptor drugs influence spatial learning in rats.

Authors:  F A Abdulla; M R Calaminici; J D Stephenson; J D Sinden
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

2.  Effects of cholinesterase inhibitors on rat nicotinic receptor levels in vivo and in vitro.

Authors:  Richard T Reid; Marwan N Sabbagh
Journal:  J Neural Transm (Vienna)       Date:  2008-08-26       Impact factor: 3.575

Review 3.  Tacrine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in Alzheimer's disease.

Authors:  A J Wagstaff; D McTavish
Journal:  Drugs Aging       Date:  1994-06       Impact factor: 3.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.